31P NMR spectroscopy of phorbol-myristate-acetate stimulated polymorphonuclear human leukocytes  by Tauber, Alfred I. & Roberts, Mary F.
Volume 129, number 1 FEBS LETTERS June 1981 
31P NMR SPECTROSCOPY OF PHORBOL-MYRISTATE-ACETATE STIMULATED 
POLYMORPHONUCLEAR HUMAN LEUKOCYTES 
Alfred I. TAUBER and Mary F. ROBERTS* 
Department of Medicine, Harvard Medical School and Divisions of Hematology and Rheumatology and Immunology, 
Brigham and Women’s Hospital, Boston, MA 02115 and *Department of Chemistry, Massachusetts Institute of Technology, 
Cambridge, MA 02139, USA 
Received 28 April 198 1 
1. Introduction 
High resolution nuclear magnetic resonance (NMR) 
of cellular suspensions and tissues has been applied in 
the study of various metabolic activities under physi- 
ologic conditions. In particular 31P NMR has been 
used to monitor intracellular pH and directly measure 
various phosphorous metabolites as a function of 
selected cellular activities [l-3]. The data herein 
reported are the first employing NMR to study the 
polymorphonuclear (PMN) leukocyte, a circulating 
blood phagocyte which serves in the initial cellular 
defense against invading microorganisms. The PMN 
leukocyte manifests a complex respiratory burst 
when activated by phagocytosable particles or by the 
soluble agonist, phorbol-12-myristate-13-acetate 
(PMA) [4]. The respiratory burst of the PMN leuko- 
cyte is characterized as cyanide-insensitive to distin- 
guish mitochondrial respiration from the activation of 
a flavin-dependent NADPH-oxidase, which reduces 
molecular oxygen to superoxide (O;), and accounts 
for the principal enzymatic activity of the respiratory 
burst [ ‘51. Reduction products of the consumed oxy- 
gen are utilized in various microbicidal mechanisms. 
31P NMR spectroscopy was employed to measure 
directly the cellular ATP pool, the pyridine nucleo- 
tide @LAD(H)) concentrations, and monitor pH fluc- 
tuation as a consequence of PMA and zymosan activa- 
tion of the human PMN leukocyte respiratory burst. 
This first report of NMR spectroscopy applied to leu- 
kocytes demonstrates the ease and utility of direct 
measurement for study of the metabolism of various 
phosphorous compounds. 
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2. Materials and methods 
Human venous blood was obtained from normal 
donors and PMN leukocytes were harvested by dex- 
tran sedimentation, hypotonic lysis, and centrifuga- 
tion over Ficoll-Paque (Pharmacia Fine Chemicals, 
Piscataway NJ) in >99% final purity as in [6]. Cells 
(3-6.7 X lo8 cells/ml in Hanks balanced salt solution 
without phenol red (Microbiological Associates, 
Walkersville MD) with 10% D*O for internal lock sig- 
nal were placed in 10 mm NMR tubes. ‘H noise- 
decoupled 31P NMR spectra at 109.3 MHz were 
obtained at 4’C with a Bruker 270 spectrometer. 
Typical acquisition parameters included 30” pulse 
angle, 0.6 s repetition rate, and 1000 transients. Under 
these conditions, none of the phosphate metabolite 
resonances were detectably saturated in these cells. 
Cells were stimulated with zymosan opsonized in 
autologous serum (6) or PMA (Sigma Chemical Co., 
St Louis MO) at a maximal stimulatory (non-cyto- 
toxic) concentration of 1 pg/ml for 10 min at 37°C. 
Spectra of activated cells were subsequently obtained 
at 4°C. 
31P chemical shifts are referenced with respect to 
external H3P04 (in some cases internal phosphocrea- 
tine was used). Determination of solution pH was 
based on the chemical shift of the Pi resonance [ 1,2]. 
Quantitation of phosphate metabolites was done with 
internal standards of known concentrations of phos- 
phocreatine and Pi added to resting cells. The data for 
resting cells are the average (and standard deviation) 
determined from spectral duplicates of 3 leukocyte 
preparations. PMA activation data are derived from 
2 different PMN leukocyte preparations and zymosan 
activation data are from a single leukocyte donor. In 
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each instance, duplicate spectral analyses were per- 
formed with each cell preparation. The ATP-/3 reso- 
nance (ml 8 ppm) was used to measure ATP concen- 
tration; ADP concentration was calculated from the 
difference in area of the ATP-y,ADP$ resonance 
(-4.8 ppm) and the ATP-/3 peak. NAD(H) was esti- 
mated by integration of a shoulder, or in some cases 
a defmed small peak at 10.5 ppm. The excess area 
(above that at 4.8 ppm) under the ATP+ADPa reso- 
nance at 9.8 ppm is labeled ‘X’ and is indicative of a 
pyrophosphate compound. Sugar phosphates were 
determined from the area under -5 to -3 ppm. 
3. Results and discussion 
3.1. Definition of NMR signal 
NMR spectra were obtained from both resting and 
PMA stimulated PMN leukocytes (fig.1). Five promi- 
nent signals were analyzed and found to correspond 
to a pool of sugar phosphates (SP) (m-4.75 ppm), 
inorganic phosphate (Pi) (m-2.6 ppm), adenosine tri- 
phosphate (ATP) (y-P at 4.8 ppm, 0-P at 18.7 ppm, 
o-P at 9.8 ppm), adenosine diphosphate (ADP), and 
pyridine dinucleotide, diphosphate (NAD (H}) 
(10.5 ppm, visible as a shoulder in A and as a well- 
defined peak in B). 
The ATP chemical shifts (y-P, 4.81 ppm; o-P, 
9.80 ppm; /3-ATP, 18.69 ppm) in resting cells, suggest 
that all ATP is complexed to Mg2+ and not free [ 11. 
The resonance peak of sugar phosphate and mono- 
phosphate nucleotide pool appears to contain little 
AMP and IMP, with relatively more glucose 6-phos- 
phate, although detailed identification in this region 
will depend on spectra of HC104 extracts [7,8]. 
3.2. pH change with stimulation 
A fall in pH was noted after 10 min leukocyte 
stimulation from the initial value of 7.1. Determined 
from the shift of the P1 signal, the pH of PMA-stimu- 
lated PMN leukocytes was 5.9-6.2 and 6.4 for zymo- 
San-activated cells. It is noteworthy that in fig.lA, the 
initial Pi signal is broad and somewhat split. This may 
represent either poorly differentiated compartmental- 
ized pools or an equilibration of Pi inside the cell 
with the external medium. 
Early work with animal granulocytes demonstrated 
the selective incorporation of 32P into phosphatidic 
acid, phosphatidylinositol, and phosphatidylserine 
upon phagocytic stimulation [9]. In our studies 
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Fig.1. (A) Cells 3 x lO’/ml resting PMN leukocytes at 4’C; 
acquisition parameters are 4000 Hz sweep width, 8192 data 
points, 30” flip angle, 896 transcents, 10 Hz line-broadening; 
(B) Cells 3 X lO*/mJ activated with PMA for 10 min at 37’C 
then cooled to 4°C for spectral acquisitions; similar parame- 
ters to (A) with the exception that 3344 transcents were 
accumulated. 
employing NMR spectroscopy, the Pi signal was not 
lost by incorporation into complex phospholipids or 
phosphoproteins upon stimulation, but was found 
predominantly in the extra-cellular medium. After 
spectrum accumulation of stimulated PMN leuko- 
cytes, the cells were centrifuged, and resuspended in 
Hanks’ solution containing <l mM phosphate (a neg- 
ligible quantity by this assay). Resuspended cells and 
the original supernatant were then again examined by 
NMR spectroscopy. Of the Pi signal, 50-75% was 
found in the extracellular supernatant. The significance 
or mechanism of secretion has not been determined. 
Studies employing phagocytozed particles which 
were stained with pH-sensitive dyes demonstrated that 
the pH within the phagocytic vacuole was 6.545.0 
for similar periods of activation [ lo,1 11. While PMA 
has been shown to induce vacuolization in PMN leu- 
kocytes [ 121, NMR spectroscopy was unable to dif- 
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Table 1 
Concentrations (nmol/lO’ cells) of phosphate compounds 
detected by 31P NMR spectroscopy of PMN leukocytes in 
resting, PMA- and zymosanactivated states 
Resting +PMAa +Zymosana 
SP 81 + 20’ 1-I f 23 134 i 30 
ATP 149?11 78 t 12 113?15 
ADP 22 f 12 22* 13 30 i 15 
Xb 342 6 50 t 32 68 5 30 
NAD(H) 
NADP(H) 
48 f 30 34It13 41 f 26 
a Activation of cells for 10 min at 37”C, prior to accumulat- 
ing the alP spectra at 4°C 
b An unidentified component of the peak at 9.80 ppm, prob- 
ably containing a pyrophosphate linkage 
’ Average + standard deviation 
ferentiate whether pH changes were uniform within 
intracellular compartments. The large pH shift (1 .O or 
0.6 units) documented represents an average extracel- 
lular level with possibly wide intracellular compart- 
ment variation. 
3.3. Assessment of A TP-ADP levels 
Integration and standardization with internal phos- 
phocreatine and Pi of the ATP-/3 phosphorous peak 
(fig.1) demonstrates 149 ? 11 nmol ATP/lO* resting 
cells. The ADP levels did not vary significantly upon 
PMA stimulation, while a significant decrease in ATP 
levels was seen (table 1). This fall in ATP concentra- 
tion is consistent with previous studies of human 
PMN leukocytes phagocytosing zymosan particles 
[ 131 and with our single experiment employing 
zymosan as the stimulus. The observation that mito- 
chondrial respiration does not maintain resting ATP 
levels subsequent to maximal stimulation is thus 
observed with both zymosan and PMA activation. 
Studies employing extraction of ATP and assay with 
the luciferase system, reported ATP values compara- 
ble to those found in these direct NMR determina- 
tions [ 13,141. The role of CAMP in the activation 
mechanism of the respiratory burst [ 15,161 or of 
ATP in modulating that activity are unsettled. That 
ATP may function as an inhibitor of the respiratory 
oxidase has been suggested for both the guinea pig 
[ 171 and human [ 181 enzymes; however we favor 
enzymatic autoinactivation [S] as the principal regu- 
lator of the activated oxidase. Excess area under the 
9.8 ppm resonance (compared to the 4.8 ppm signal) 
was assigned to an unidentified pyrophosphate dies- 
ter. Such discrepancies have also been seen in per- 
fused heart spectra [ 11. 
3.4. Pyridine nucleotide concentrations 
By integration of the shoulder at 10.5 ppm, 
NAD(H) levels are estimated to be 34-48 nmol/108 
cells (table 1). This value though error-prone because 
it overlaps with the ATP-a,ADP-o peak remained con- 
stant during PMA and zymosan stimulation which 
reflects that both the oxidized and reduced forms are 
pooled in this determination. Determinations in 
[ 19,201 of NADP(H) and NAD(I-I) levels in human 
PMN leukocytes are 14- 16 nmol/ 1 O8 cells, a figure 
l/2-1/3 that reported here. The discrepancies may 
reflect differences of efficiency between methods 
relying upon extraction procedures with chemical 
assay and direct NMR observation. 
These findings demonstrate the feasibility of 
applying 31P NMR spectroscopy to the study of 
human PMN leukocytes. The technical ease and accu- 
racy of determining the concentration of various 
phosphate-containing compounds, their sensitivity to 
pH shifts, and the ability to separate intra- and extra- 
cellular components of the 31P NMR signal, further 
illustrate the broad applicability of such methodol- 
ogy. From these studies, the significance of the 
appearance of extracellular phosphate and a pH gra- 
dient established by PMA stimulated PMN leukocytes 
are the subject of continued study. 
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